Isosorbide dinitrate labels and packages: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Pratik Bahekar (talk | contribs)
nocaptcha
3,696 edits
No edit summary
Pratik Bahekar (talk | contribs)
nocaptcha
3,696 edits
No edit summary
Line 31: Line 31:
|}
|}


'''PRINCIPAL DISPLAY PANEL - 40 mg Label
PRINCIPAL DISPLAY PANEL - 40 mg Label
NDC 64455-192-01
NDC 64455-192-01
Isordil®40
Isordil®40

Revision as of 15:21, 31 January 2014

Isosorbide dinitrate
ISORDIL® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Description
Clinical Pharmacology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

Isordil® is a registered trade mark of Biovail Laboratories International SRL.

Manufactured by: MEDA Manufacturing GmbH Cologne, Germany D-51063

For: BTA Pharmaceuticals, Inc. Bridgewater, NJ, 08807, USA

PRINCIPAL DISPLAY PANEL - 5 mg Label

NDC 64455-152-01 Isordil®5 (isosorbide dinitrate)

5 mg TITRADOSE™ 100 Tablets Rx ONLY BIOVAIL®

PRINCIPAL DISPLAY PANEL - 40 mg Label NDC 64455-192-01 Isordil®40 (isosorbide dinitrate) 40 mg TITRADOSE™ 100 Tablets Rx ONLY BIOVAIL®


[1]

References

  1. ↑ "ISORDIL (ISOSORBIDE DINITRATE) TABLET [BTA PHARMACEUTICALS, INC.]". Retrieved 30 January 2014.
Retrieved from "https://www.wikidoc.org/index.php?title=Isosorbide_dinitrate_labels_and_packages&oldid=936480"